Publications en collaboration avec des chercheurs de Hospital Universitario Virgen del Rocío (469)

2024

  1. A Pilot Study on Proteomic Predictors of Mortality in Stable COPD

    Cells, Vol. 13, Núm. 16

  2. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain

    AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314

  3. Atezolizumab Combined with Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer with a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial

    Journal of Clinical Oncology

  4. Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma

    Clinical Cancer Research, Vol. 30, Núm. 10, pp. 2085-2096

  5. COPD: systemic proteomic profiles in frequent and infrequent exacerbators

    ERJ Open Research, Vol. 10, Núm. 2

  6. Clinical characteristics and prognostic factor in juvenile dermatomyositis: data of the Spanish registry

    Pediatric Rheumatology , Vol. 22, Núm. 1

  7. Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance

    Journal of Clinical Oncology, Vol. 42, Núm. 27, pp. 3247-3256

  8. ECLIM-SEHOP: how to develop a platform to conduct academic trials for childhood cancer

    Clinical and Translational Oncology, Vol. 26, Núm. 9, pp. 2351-2359

  9. Early use of teduglutide in paediatric patients with intestinal failure is associated with a greater response rate: a multicenter study

    European Journal of Pediatrics, Vol. 183, Núm. 8, pp. 3173-3182

  10. Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial

    The Lancet Infectious Diseases, Vol. 24, Núm. 4, pp. 375-385

  11. Factors associated with discharge home in older patients admitted to emergency department observation units: Looking for a predictive scale

    Journal of Evaluation in Clinical Practice

  12. Feasibility and Short-Term Outcomes in Liver-First Approach: A Spanish Snapshot Study (the RENACI Project)

    Cancers, Vol. 16, Núm. 9

  13. Heteroatom-tagged proteomics of lung cancer and chronic obstructive pulmonary disease human serum reveal alterations in selenoproteins

    Microchemical Journal, Vol. 199

  14. Hyperactive delirium during emergency department stay: analysis of risk factors and association with short-term outcomes

    Internal and Emergency Medicine, Vol. 19, Núm. 2, pp. 535-545

  15. Ibrutinib in Combination with R-GemOx in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma of Nongerminal Center B-cell-like Type: Phase II Clinical Trial of the Spanish GELTAMO Group

    Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 30, Núm. 17, pp. 3704-3714

  16. Improvement of thrombosis management in patients with cancer: a practical consensus document of recommendations for cancer-associated thrombosis patients’ healthcare in Spain

    Clinical and Translational Oncology, Vol. 26, Núm. 6, pp. 1319-1328

  17. Incidence of Diabetes Mellitus and Associated Factors in the Era of Antiretroviral Drugs With a Low Metabolic Toxicity Profile

    Open Forum Infectious Diseases, Vol. 11, Núm. 4

  18. Individualised, perioperative open-lung ventilation strategy during one-lung ventilation (iPROVE-OLV): a multicentre, randomised, controlled clinical trial

    The Lancet Respiratory Medicine, Vol. 12, Núm. 3, pp. 195-206

  19. Induction avelumab followed by chemoimmunotherapy and maintenance versus chemotherapy alone as first-line therapy in cis-ineligible metastatic urothelial carcinoma (INDUCOMAIN): a randomized phase II study

    ESMO Open, Vol. 9, Núm. 9

  20. L-serine treatment in patients with GRIN-related encephalopathy: A phase 2A, non-randomized study

    Brain, Vol. 147, Núm. 5, pp. 1653-1666